Easywell Biomedicals, Inc., the former name Actherm, Inc., is a multinational biomedical company dedicated to working with medical devices, Rx-to-OTC drugs and new formulation drugs. Headquartered in HsinChu, Taiwan, the company also owns a GMP manufacturing plant in ShenZhen, China for medical devices and a cGMP manufacturing plant in Cranbury, New Jersey, USA for Rx-to-OTC and new formulation drugs.
Incorporated in July 1998, the company was focused on electronic measuring devices with CE mark and USFDA clearance, mainly digital clinical thermometers, infrared ear thermometers and the recently launched Transcutaneous Electrical Nerve Stimulation (TENS) products for pain relief. In August 2014, Easywell Biomedicals acquired a US specialty pharmaceutical company focusing on developing unique drug delivery technologies as well as difficult to formulate generics, and then transformed itself into a drug development company. The Rx-to-OTC product pipeline includes cough and gastrointestinal drugs, furthermore, several new formulation CNS drugs are under development as well.
The Easywell Biomedicals team is composed of seasoned professionals experienced in the design, development, production, marketing, and sales of both medical devices and drugs; as a result, the company is committed to create synergy between these two areas to develop companion diagnostics and drug-device combination products.
The goal of Easywell Biomedicals is to improve the drug safety and efficacy, and facilitate better patient compliance to benefit human health.